Risperidone
CAS No. 106266-06-2
Risperidone ( Apexidone;R-64766;R64766 )
产品货号. M10279 CAS No. 106266-06-2
An antipsychotic agent with serotonin-S2 and dopamine-D2 antagonistic properties.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
10MG | ¥348 | 有现货 |
|
25MG | ¥437 | 有现货 |
|
50MG | ¥689 | 有现货 |
|
100MG | ¥1053 | 有现货 |
|
200MG | ¥1725 | 有现货 |
|
500MG | ¥2900 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Risperidone
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述An antipsychotic agent with serotonin-S2 and dopamine-D2 antagonistic properties.
-
产品描述An antipsychotic agent with serotonin-S2 and dopamine-D2 antagonistic properties; also has actions at several 5-HT receptor subtypes, adrenergic receptors and histamine H1 receptors.Schizophrenia Approved
-
同义词Apexidone;R-64766;R64766
-
通路Endocrinology/Hormones
-
靶点5-HT Receptor
-
受体5-HT2A;D2;D2L;D3;α2C-adrenergicreceptor
-
研究领域Neurological Disease
-
适应症Schizophrenia
化学信息
-
CAS Number106266-06-2
-
分子量410.48
-
分子式C23H27FN4O2
-
纯度>98% (HPLC)
-
溶解度DMSO: < 4.1 mg/mL
-
SMILESO=C1C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)=C(C)N=C5N1CCCC5
-
化学全称4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Janssen PA, et al. J Pharmacol Exp Ther. 1988 Feb;244(2):685-93.
2. Megens AA, et al. Psychopharmacology (Berl). 1988;95(4):493-6.
3. Dugovic C, et al. Neuropharmacology. 1989 Dec;28(12):1431-3.
4. Smith C, et al. Mol Pharmacol. 2006 Oct;70(4):1264-70.
2. Megens AA, et al. Psychopharmacology (Berl). 1988;95(4):493-6.
3. Dugovic C, et al. Neuropharmacology. 1989 Dec;28(12):1431-3.
4. Smith C, et al. Mol Pharmacol. 2006 Oct;70(4):1264-70.
产品手册
关联产品
-
Thioridazine hydroch...
Thioridazine is an antipsychotic drug, used in the treatment of schizophrenia and psychosis, shows D4 selectivity or serotonin antagonism.
-
AC-90179 HCl
AC-90179 HCl is a selective inverse agonist of 5-HT2A receptor. AC-90179 HCl is an atypical antipsychotic pharmaceutical and has been shown to alleviate hallucinogen-induced vasocontriction.
-
RG2833
RG2833 (RGFP109), a brain-penetrant HDAC inhibitor, is with IC50 of 60 nM and 50 nM for HDAC1 and HDAC3, respectively.